Group 1 - As of August 22, 2025, Yunnan Baiyao's stock price closed at 57.64 yuan, with an increase of 0.14 yuan, representing a 0.24% rise [1] - The trading volume on that day was 145,522 hands, with a total transaction amount of 8.35 billion yuan [1] - Yunnan Baiyao operates in the traditional Chinese medicine sector, with its main business covering pharmaceuticals, health products, Chinese medicine resources, and pharmaceutical commerce [1] Group 2 - The company announced that its wholly-owned subsidiary, Yunnan Baiyao Group Chinese Medicine Resources Co., Ltd., will acquire 100% equity of An Guo Shi Ju Yao Tang Pharmaceutical Co., Ltd. for 660 million yuan [1] - Ju Yao Tang is a significant player in the northern Chinese herbal medicine market, with 1,567 types of herbal pieces and 240 standard备案 varieties of formula granules [1] - This acquisition is viewed as a strategic move for Yunnan Baiyao to strengthen its herbal medicine business and expand its presence in the northern market [1] Group 3 - On August 22, Yunnan Baiyao experienced a net inflow of main funds amounting to 55.8873 million yuan, with a cumulative net inflow of 128.6628 million yuan over the past five days [1]